Immunome (IMNM) Share-based Compensation Growth (3y) (2022 - 2026)
Immunome (IMNM) Share-based Compensation Growth (3y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
4.80% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
10.78% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Immunome |
2.12 Bn |
1.54 Bn |
- |
86.60% |
| Date | Value |
|---|
| Mar 31, 2026 |
86.60% |
| Dec 31, 2025 |
79.93% |
| Sep 30, 2025 |
71.40% |
| Jun 30, 2025 |
59.13% |
| Mar 31, 2025 |
63.28% |
| Dec 31, 2024 |
64.94% |
| Sep 30, 2024 |
61.80% |
| Jun 30, 2024 |
62.72% |
| Mar 31, 2024 |
87.98% |
| Dec 31, 2023 |
108.30% |
| Sep 30, 2023 |
10.62% |
| Jun 30, 2023 |
198.09% |
| Mar 31, 2023 |
103.15% |
| Dec 31, 2022 |
667.25% |
| Sep 30, 2022 |
1,002.47% |
